In order to begin exploring the mechanism underlying how BMDHs develop and function to repopulate the liver after BMT to treat hepatic failure, Fah−/− mice were transplanted with WT BMCs and monitored for more than 30 weeks after NTBC withdrawal. The gene discussed is FAH; the disease is Hepatic failure.